Chamberlain University: Streptococcal Pharyngitis Report and Analysis

This report provides a detailed analysis of Streptococcal Pharyngitis, also known as strep throat, caused by Group A Streptococcus (GAS). It begins with an abstract summarizing key aspects of the infection, including symptoms like sore throat, fever, and swollen lymph nodes, along with the mode of transmission via respiratory droplets. The report then delves into pathogen information, classifying GAS based on hemolysis and serologic characteristics, and discussing its cellular structure and virulence factors. It explores the susceptibility of GAS to antibiotics, specifically penicillin and amoxicillin, detailing their mechanisms of action and addressing the increasing concerns of antibiotic resistance. The report also examines the growth conditions of GAS and its strategies for immune evasion, such as producing the S protein to avoid phagocytosis. Furthermore, it discusses the diseases caused by streptococci, including skin and respiratory infections, and the potential for serious complications like rheumatic fever. The report is based on the assignment brief requiring the inclusion of article summaries, pathogen information, antibiotic susceptibility, and other related details.

Running head: STREPTOCOCCAL PHARYNGITIS
1
Streptococcal pharyngitis
Name
Institutional affiliation

STREPTOCOCCAL PHARYNGITIS 2
Streptococcal pharyngitis
Abstract
Streptococcal pharyngitis is a contamination of the rear of the throat including the tonsils
brought about by group A streptococcus. Common indications incorporate sore throat, fever, and
amplified lymph hubs in the neck and red tonsils. Strep throat is spread by respiratory beads
from a tainted person. It might be spread legitimately or by contacting something that has beads
on it and afterward contacting the nose, mouth, or eyes. Some individuals may convey the
microscopic organisms without symptoms.
Summary
Group A Streptococcal contaminations cause the immune system illness intense rheumatic fever
(ARF), which can advance to ceaseless rheumatic coronary illness. Treating pharyngitis brought
about by Gas with anti-toxins is significant in forestalling ARF. It is hard to recognize these
contaminations from GAS bearers. There is developing proof for GAS skin diseases as a reason
for ARF.
Pathogen Information
Streptococci are characterized based on hemolysis, state, biochemical responses, serologic
particularity and morphology. They are separated into three gatherings by the kind of hemolysis
on blood agar: γ hemolytic, α hemolytic, and β-hemolytic (Bennett, Moreland & Baker, 2019).
Serologic gathering depends on antigenic contrasts in starches of cell divider, cell divider pili-
related protein, as well as in the polysaccharide container in group B streptococci.
Susceptibility to antibiotics

STREPTOCOCCAL PHARYNGITIS 3
GAS is the most widely recognized reason for bacterial pharyngitis in kids. The recurrences of
obstruction of this life form to anti-infection agents and the quantity of medications to which
they are safe have been expanding overall. Right now, penicillin amoxicillin is the medication of
decision for GAS pharyngitis treatment, and penicillin protection from GAS has not been
accounted for yet (Luo, Sickler & Thompson, 2019). Penicillin structure contains an acyl amino
side chain and a beta-lactum ring. Penicillin docks itself into the bacterial leading to its
destruction.
Growth conditions
S. pyogenes is an anaerobe (facultative) that is developed at 37°C in either encompassing air or
in 5–10% of carbon IV oxide. It depends on a media rich of fermented sugars for energy
production of energy and growth. Explicit parts of a rich development mechanism for GAS
incorporate glucose as carbon source, neo peptone extricates and a mind boggling blend of
supplements from meat heart mixture as first portrayed by Sharrif, Aalinezhad, Sajadian and
Razaei, (2016). GAS is viewed as a different amino corrosive auxotroph requiring almost all
amino acids to be available in its media of development.
Immune evasion
A bacterial pathogen that causes strep throat shrouds itself in blood cells (red) to avoid
recognition by immune system of the host. The specialists found that Group A Streptococcus
delivers a formerly uncharacterized protein, named S protein, which ties to the red platelet film
to abstain from being immersed and devastated by phagocytic insusceptible cells (Bennett,
Moreland & Baker, 2019). By furnishing GAS with this type of invulnerable disguise, S protein
improves bacterial destructiveness and diminishes endurance in tainted mice.

STREPTOCOCCAL PHARYNGITIS 4
Diseases
Streptococci are responsible for wide assortment of maladies in people. During spring and winter
in calm atmospheres, about 20% of asymptomatic school kids might have group A streptococcus
(Ashurst & Edgerley-Gibb, 2020). Notwithstanding contaminations of the skin and the upper
respiratory tract, S pyogenes can bring a wide assortment of intrusive fundamental diseases to
people. What's more, contamination with S pyogenes has reappeared as a significant reason for
poisonous stun disorder and of hazardous skin and delicate tissue diseases, particularly
necrotizing fasciitis.

STREPTOCOCCAL PHARYNGITIS 5
References
Ashurst, JV. & Edgerley-Gibb, L. (2020). Streptococcal pharyngitis. Statpearls.
Retrieved from:
https://www.ncbi.nlm.nih.gov/books/NBK525997/#_NBK525997_pubdet_
Bennett, J., Moreland, N. & Baker, M. (2019). Understanding group A Streptococcal
Pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective
disease incident study. BMC infectious diseases, 19(633). Retrieved from:
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-4126-9
Luo, R., Sickler, J. & Thompson, M. (2019). Diagnosis and management of group A
Streptococcal pharyngitis in the United States. BMC infectious diseases, 19(193).
Retrieved from: https://pubmed.ncbi.nlm.nih.gov/30808305/
Sharrif, M., Aalinezhad, M., Sajadian, S. & Razaei, M. (2016). Streptococcal pharyngitis
In two-month-old infant: a case report. Jundishapur university of medical sciences,
17(21), 1-10. Retrieved from: http://jjmicrobiol.com/articles/56653.html